Structure‐Activity Relationship Studies of CNS Agents, XV: N‐[ω‐(4‐Aryl‐1‐piperazinyl)alkyl]‐2‐oxo‐1,2,3,4‐tetrahydroquinolines and ‐4‐oxo‐1,2,3,4‐tetrahydropyrazino[1,2‐a]indoles: New, Highly Potent 5‐HT1A Ligands ωN‐[ω‐(4‐Aryl‐1‐piperazinyl)alkyl]‐2‐oxo‐1,2,3,4‐tetrahydrochinoline und ‐4‐oxo‐1,2,3,4‐tetrahydropyrazino‐[1,2‐a]indole: Neue starke 5‐HT1A Liganden
- 1 January 1994
- journal article
- kurzmitteilung
- Published by Wiley in Archiv der Pharmazie
- Vol. 327 (8) , 529-531
- https://doi.org/10.1002/ardp.19943270811
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Concepts for the design of 5‐HT1A serotonin agonists and antagonistsDrug Development Research, 1992
- The discovery and development of buspirone: A new approach to the treatment of anxietyMedicinal Research Reviews, 1990
- Activity of aromatic substituted phenylpiperazines lacking affinity for dopamine binding sites in a preclinical test of antipsychotic efficacyJournal of Medicinal Chemistry, 1989
- Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbensEuropean Journal of Pharmacology, 1987
- Antidepressant drugs given repeatedly increase binding to α1-adrenoceptors in the rat cortexEuropean Journal of Pharmacology, 1985